Scribe’s CRISPR-based cholesterol reduction therapy is part of a three-pronged approach to combating cardiovascular disease. Genetic medicine biotech Scribe Therapeutics…
Credit: boonchai wedmakawand/Getty Images Personalized medicine for cardiovascular disease (CVD) could receive a huge boost through the application of the…
